• Product NameLeterMovir
  • CasNo. 917389-32-3
  • MF
  • MW572.559
  • Purity
  • Appearance
  • Packing
  • Contact usInquiry

Product Details

CasNo: 917389-32-3

Manufacturer supply high quality LeterMovir 917389-32-3 with ISO standards

  • Molecular Formula:C29H28F4N4O4
  • Molecular Weight:572.559
  • Boiling Point:706.5±70.0 °C(Predicted) 
  • PKA:4.00±0.10(Predicted) 
  • Density:1.37±0.1 g/cm3(Predicted) 

917389-32-3 Relevant articles

PROCESS FOR THE PREPARATION OF AN INTERMEDIATE USED IN THE SYNTHESIS OF LETERMOVIR

-

Page/Page column 25, (2022/02/05)

Disclosed is an enantioselective process...

NOVEL PROCESSES FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS USING HYDROGEN BONDING CATALYSTS

-

Page/Page column 25; 26, (2017/08/01)

Disclosed herein is a novel process for ...

Access to Chiral Hydropyrimidines through Palladium-Catalyzed Asymmetric Allylic C?H Amination

Wang, Pu-Sheng,Shen, Meng-Lan,Wang, Tian-Ci,Lin, Hua-Chen,Gong, Liu-Zhu

supporting information, p. 16032 - 16036 (2017/11/23)

A palladium-catalyzed asymmetric intramo...

Asymmetric synthesis of letermovir using a novel phase-Transfer-catalyzed aza-michael reaction

Humphrey, Guy R.,Dalby, Stephen M.,Andreani, Teresa,Xiang, Bangping,Luzung, Michael R.,Song, Zhiguo Jake,Shevlin, Michael,Christensen, Melodie,Belyk, Kevin M.,Tschaen, David M.

, p. 1097 - 1103 (2017/01/16)

The development of a concise asymmetric ...

917389-32-3 Process route

(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate ethyl acetate

(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate ethyl acetate

(S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)-phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid
917389-32-3

(S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)-phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid

Conditions
Conditions Yield
(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate ethyl acetate; With disodium hydrogenphosphate; tert-butyl methyl ether; In water; for 2h;
With sodium hydroxide; In water; at 60 ℃; for 5h; Inert atmosphere;
94%
(S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate ethyl acetate; With sodium phosphate dibasic dihydrate; water; In tert-butyl methyl ether; at 20 ℃; for 0.666667h;
With water; potassium hydroxide; In methanol; tert-butyl methyl ether; at 50 ℃; for 6h;
92%
(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester
917389-30-1

(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester

(S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)-phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid
917389-32-3

(S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)-phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid

Conditions
Conditions Yield
With water; sodium hydrogencarbonate; sodium hydroxide; In tert-butyl methyl ether; Reflux; Large scale;
96.4%
With water; sodium hydrogencarbonate; sodium hydroxide; In tert-butyl methyl ether; at 22 ℃; Reflux; Large scale;
96.4%
With water; sodium hydrogencarbonate; In tert-butyl methyl ether; Large scale;
96.4%
(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester; With sodium phosphate dibasic dihydrate; In tert-butyl methyl ether; water; at 20 ℃; for 0.666667h;
With potassium hydroxide; In methanol; tert-butyl methyl ether; water; at 50 ℃; for 6h;
With hydrogenchloride; In tert-butyl methyl ether; water; pH=4 - 5;
92%
(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester; With water; sodium hydrogencarbonate; In ethyl acetate;
With sodium hydroxide; water; In 1,4-dioxane; at 20 ℃; for 3 - 18h;
With hydrogenchloride; water; In 1,4-dioxane; isobutyl methyl ether; pH=7.0 - 7.5; Product distribution / selectivity;
81.2%

917389-32-3 Upstream products

  • 917389-30-1
    917389-30-1

    (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]succinic acid {(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-(trifluormethyl)phenyl)-3,4-dihydroquinazolin-4-yl}acetic acid methyl ester

  • 917389-34-5
    917389-34-5

    (R)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate

  • 917389-21-0
    917389-21-0

    methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl)acetate

  • 348-54-9
    348-54-9

    2-Fluoroaniline

Relevant Products